ReviewRheumatology international2025
Fast-track capillaroscopic progression in systemic sclerosis: a case-based review of active pattern emerging within 3 months of raynaud's phenomenon onset.
Review in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nailfold videocapillaroscopy typically shows a gradual progression through early, active, and late scleroderma patterns over years in systemic sclerosis. Rapid evolution directly to active pattern within months of Raynaud's phenomenon onset is rarely documented. We report a 39-year-old non-smoking Caucasian woman who developed Raynaud's phenomenon in April 2025. Nailfold videocapillaroscopy performed three months later revealed an active scleroderma pattern characterized by multiple megacapillaries, microhemorrhages, and reduced capillary density, bypassing the typical early pattern phase. Antinuclear antibodies were positive at 1:320 with centromere pattern. The patient met the criteria for early systemic sclerosis (SSc) in accordance with LeRoy and Medsger, and showed high risk for progression to definite systemic sclerosis. This case demonstrates that rapid progression to active scleroderma pattern can occur within three months of Raynaud's onset, challenging the conventional understanding of capillaroscopic evolution timing. Early capillaroscopy in recent-onset Raynaud's phenomenon may identify patients at accelerated risk for systemic sclerosis development, with important implications for monitoring and early intervention strategies.
Indexed as
Identifiers
40839312What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.